 Connection
Robert MacLaren to Hemorrhage
This is a "connection" page, showing publications Robert MacLaren has written about Hemorrhage.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.942 |
|
|
|
-
MacLaren R. Key concepts in the management of difficult hemorrhagic cases. Pharmacotherapy. 2007 Sep; 27(9 Pt 2):93S-102S.
Score: 0.180
-
Maclaren R. Factor VIIa: mounting evidence or anecdotal reports. J Postgrad Med. 2007 Jan-Mar; 53(1):4-5.
Score: 0.172
-
MacLaren R, Weber LA, Brake H, Gardner MA, Tanzi M. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes. Transfusion. 2005 Sep; 45(9):1434-42.
Score: 0.157
-
Stevens VM, Trujillo TC, Kiser TH, MacLaren R, Reynolds PM, Mueller SW. Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:10760296211039020.
Score: 0.114
-
Curry B, Mueller S, MacLaren R. The Use of Prothrombin Complex Concentrates: Results of a Nationwide Survey of Critical Care Pharmacists. J Pharm Pract. 2022 Apr; 35(2):197-204.
Score: 0.112
-
Kwon JO, MacLaren R. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study. Pharmacotherapy. 2016 10; 36(10):1047-1054.
Score: 0.084
-
MacLaren R, Bond CA. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events. Pharmacotherapy. 2009 Jul; 29(7):761-8.
Score: 0.051
-
Owen PS, Golightly LK, MacLaren R, Ferretti KA, Badesch DB. Formulary management of recombinant factor VIIa at an academic medical center. Ann Pharmacother. 2008 Jun; 42(6):771-6.
Score: 0.047
-
Van Matre ET, Reynolds PM, MacLaren R, Mueller SW, Wright GC, Moss M, Burnham EL, Ho PM, Vandivier RW, Kiser TH. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer. J Thromb Haemost. 2018 12; 16(12):2492-2500.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|